Corticosteroid treatment in active Crohn's disease

Acta Gastro-Enterologica Belgica

Volumn 61, Issue 2, 1998, Pages 153-157

  Belaiche, J ^a   Louis, E ^a  

^a CHU SART TILMAN   (Belgium)

Author keywords

Active disease; Budesonide; Crohn's disease; Prednisolone

Indexed keywords

BUDESONIDE; CALCIUM; METHYLPREDNISOLONE; PLACEBO; PREDNISOLONE; VITAMIN D;

ACNE; BONE NECROSIS; CATARACT; CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROHN DISEASE; DOSE RESPONSE; DRUG TOLERANCE; DRUG WITHDRAWAL; HUMAN; MYOPATHY; ORAL DRUG ADMINISTRATION; OSTEOPENIA; PROSPECTIVE STUDY; RELAPSE; REMISSION; REVIEW; TREATMENT INDICATION; TREATMENT PLANNING;

ADMINISTRATION, ORAL; ADRENAL CORTEX HORMONES; CLINICAL TRIALS; CROHN DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; TREATMENT OUTCOME;

EID: 0031842236     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. MEYERS S , SACHAR D B Medical therapy of Crohn's disease In : J B. KIRSNER, R G SHORTED (eds), Inflammatory bowel disease (fourth edition). Williams & Wilkins, Baltimore, Philadelphia, 1995, p. 695-714.
2. SUMMERS R.W., SWITZ D.M., SESSIONS Jr J T. et al. National Cooperative Crohn's Disease Study. results of drug treatment. Gastroenterology, 1979, 77 847-869
3. MALCHOW H., EWE K , BRANDES J W et al European Cooperative Crohn's Disease Study . results of drug treatment Gastroenterology, 1984, 86 : 249-266.
4. MUNKHOLM P., LANGHOLZ E, DAVIDSEN M., BINDER V Frequency of glucocorticoid resistance and dependency in Crohn's disease. Gut, 1994, 35 : 360-362.
5. MODIGLIANI R., MARY J Y , SIMON J.F. et al. Clinical, biological and endoscopic picture of attacks of Crohn's disease. evolution on prednisone Gastroenterology, 1990, 98 . 811-818.
6. BRIGNOLA C., DE SIMONE G., LANNONE I et al Influence of steroid treatment duration in patients with active Crohn's disease Agents actions Special conference issue 1992 C90-C92.
7. LANDI B, N'GUYEN ANH T , CORTOT A. et al Endoscopic monitoring of Crohn's disease treatment : a prospective randomized clinical trial. Gastroenterology, 1992, 102 1647-1653.
8. BRIGNOLA C., CAMPIERI M., BAZOCCHI G et al A laboratory index for predicting relapse in asymptomatic patients with Crohn's disease. Gastroenterology, 1986, 91 : 1490-1494.
9. BRIGNOLA C., IANNONF P , BELLOLI C et al. Prediction of relapse in patients with Crohn's disease in remission : a simplified index using laboratory tests, enhanced by clinical characteristics Eur J. Gastroenterol Hepato., 1994, 6 : 955-961.
10. LOUIS E , BELAICHE J., VAN KEMSEKE C. et al. Soluble interleukin-2 receptor in Crohn's disease. Assessment of disease activity and prediction of relapse. Dig. Disease Sciences, 1995, 40 : 1750-1756.
11. LOUIS E., BELAICHE J , VAN KEMSEKE C. et al Crohn's disease relapse by interleukin-6 serum level Eur. J. Gastro Hepato (in press).
12. SINGLETON J.W., SUMMERS R.W., KERN F. et al. A trial of sulfasalazine as an adjunctive therapy in Crohit's disease Gastroenterology, 1979, 77 , 8887-8897.
13. MODIGLIANI R., COLOMBEL J F., DUPAS J L et al Mesalamine in Crohn's disease with steroid-induced remission effect on steroid withdrawal and remission maintenance. Gastroenterology, 1996, 110 : 688-693
14. EWE K., PRESS A G., SINGE C.C. et al. Azathioprine combined with prednisolone or monotherapy with prednisolone in active Crohn's disease. Gastroenteroloy, 1993, 105 367-372
15. LEREBOURS E., GALMICHE J.P. FOUIN-FORTUNET H. et al. Etude de l'utilité d'une corticothérapie au cours des poussées aigues de maladie de Crohn traitées par alimentation parentérale. Gastroenterol. Cllin. Biol , 1982, 6 : 1450-1455.
16. VAKIL N., SPARBERG M. Steroid-related osteonccrosis in inflarnmatory bowel disease. Gastroenterology, 1989, 96 : 62-67.
17. COMPSTON J.E., JUDD D., CRAWLEY E O. et al Osteoporosis in patients with inflammatory bowel disease Gut, 1987, 28 : 410-415.
18. PIGOT F., ROUX C., CHAUSSADE S. et al Low bone mineral density in patients with inflammatory bowel disease. Dig. Dis Sci., 1992, 37 1396-1403
19. ROUX C., ABITBOL V., CHAUSSADE S. et al. Bone loss in patients with inflammatory bowel disease . a prospective study. Osteoporosis Int , 1995, 5 . 156-160.
20. CROUCHER P.I., VEDI S., MOTLEY R.J. et al Reduced bone formation in patients with osteoporosis associated with inflammatory bowel disease. Osteoporosis Int., 1993, 3 : 236-241.
21. ABITBOL V., ROUX C., CHAUSSADE S. et al. Metabolic bone assesment in patients with inflammatory bowel disease Gastroenterology. 1995, 108 : 417-422.
22. GREENBERG G.R., FEAGAN B.G., MARTIN F. et al. Oral budesonide for active Crohn's disease. N Engl J Med. 1994, 331 : 836-841.
23. GROSS V., CAESAR I., ANDUS T. et al. Dose-finding study with oral budesonide in patients with active Crohn's ileocolitis. Gastroenterology, 1997, 112 (4 suppl.) : A 986 (abstr.).
24. CAMPIERI M., FERGUSON A., DOE W et al. Oral budesonide is as effective as oral prednisolone in active Crohn's disease Gut, 1997, 41 : 209-214.
25. RUTGEERTS P., LOFBERG R., MALCHOW H. et al. A comparison of budesonide with prednisolone for active Crohn's disease. N. Engl. J. Med., 1994, 331 : 842-845.
26. SACHAR D B Budesonide for inflammatory bowel disease. Is it a magic bullet ? N. Engl. J. Med., 1994, 331 : 873-874.
27. SINGLETON J.W., HANAUER S.B , GITNICK G.L. et al Mesalamine capsules for the treatment of active Crohn's disease : result of a 16-week trial Gastroenterology, 1993, 104 : 1293-1301.
28. THOMSEN O.O., CORTOT A., JEWELL D. et al. Budesonide CIR is more effective than mesalazine in active Crohn's disease. A 16 week, international randomized double-blind multicentrique trial. Gastroenterology, 1997, 112 (4 suppl) : A 1104 (abstr.)
29. LOFBER R. New steroids for inflammatory bowel disease Inflamm. Bowel Dis , 1995, 1 , 135-141.
30. WRJGHT J P., JARNUM S., SCHAFFALITZKY DE MUCKADEL O et al. Oral fluticasone propionate compared with prednisolone in treatment of active Crohn's disease : a randomized double-blind multicentre study. Eur J. Gastro Hepato., 1993, 5 : 499-503.
31. D'HAENS G.R., RUTGEERS P. How should corticosteroids be used in inflammatory bowel disease ? Clinical Immunotherapeutics, 1996, 5 : 334-340
32. ANDUS T., GROSS V., CAESAR T, et al. Replacement of conventional steroids by budesonide in active or inactive Crohn's disease. Interim analysis of an open, prospective, multicenter trial. Gastroenterology, 1995, 108 : A 771 (abstr.).
33. NOVACEK G , KLEINBERGER M., VOGELSANG H. et al Budesonide in glucocorticoid dependent chronic active Crohn's disease, a pilot study Z gastroenterol , 1995, 33 : 251-254.
34. PRANTERA C., ZANNONI F., SCRIBANO M.I. et al. An antibiotic regimen for the treatment of Crohn's disease - a randomized, controlled clinical trial of metronidazole plus ciprofloxacine Am. J. Gastroenterol., 1996, 91 : 328-332
35. FELINER J.B , ADLER D J., KORELITZ B.I. The safety of corticosteroid therapy in Crohn's disease with an abdominal mass. Am. J. Gastroenterol., 1991, 86 : 1450-1455